Science Explorer Back to mapMap

Most cited papers from Crown Bioscience (China)

What are the most cited papers from Crown Bioscience (China)?

The most cited paper from Crown Bioscience (China) is "Present and Future of Surface-Enhanced Raman Scattering" (Judith Langer et al., 2019), with 3,910 citations. Next come "Targeting LIF-mediated paracrine interaction for pancreatic cancer therapy and monitoring" (437) and "Measurement of single-cell dynamics" (415).

Showing 50 of 61 papers. Every paper with more than 20 citations is listed.

Most cited papers, sortable by citations and release date
#Paper
1 Present and Future of Surface-Enhanced Raman Scattering Judith Langer et al. · ACS Nano Open access 3 Sep 2019 3,910
2 Targeting LIF-mediated paracrine interaction for pancreatic cancer therapy and monitoring Yu Shi et al. · Nature Open access 17 Apr 2019 437
3 Measurement of single-cell dynamics David G. Spiller, Christopher D. Wood, David A. J. Rand et al. · Nature Jun 2010 415
4 De novo design of a fluorescence-activating β-barrel Jiayi Dou, Anastassia Andreevna Vorobieva, William Sheffler et al. · Nature Open access 11 Sep 2018 390
5 Uniform nomenclature for the mitochondrial contact site and cristae organizing system Nikolaus Pfanner et al. · The Journal of Cell Biology Open access 31 Mar 2014 262
6 Co-delivery nanoparticles of anti-cancer drugs for improving chemotherapy efficacy Shanshan Qi, Jia-Hui Sun, Hao-Han Yu et al. · Drug Delivery Open access 2017 217
7 Identification of apilimod as a first-in-class PIKfyve kinase inhibitor for treatment of B-cell non-Hodgkin lymphoma Sophia Gayle, Sean F. Landrette, Neil Beeharry et al. · Blood Open access 20 Jan 2017 214
8 LY2801653 is an orally bioavailable multi-kinase inhibitor with potent activity against MET, MST1R, and other oncoproteins, and displays anti-tumor activities in mouse xenograft models Sau-Chi Betty Yan et al. · Investigational New Drugs Open access 27 Dec 2012 165
9 Biomarker Analyses from a Placebo-Controlled Phase II Study Evaluating Erlotinib ± Onartuzumab in Advanced Non–Small Cell Lung Cancer: MET Expression Levels Are Predictive of Patient Benefit Hartmut Koeppen et al. · Clinical Cancer Research Open access Apr 2014 137
10 Label-free mass spectrometry-based protein quantification technologies in proteomic analysis Mu Wang, Jingjing You, Kerry G. Bemis et al. · Briefings in Functional Genomics and Proteomics Open access 25 Jun 2008 132
11 Characterization of LY2228820 Dimesylate, a Potent and Selective Inhibitor of p38 MAPK with Antitumor Activity Robert M. Campbell et al. · Molecular Cancer Therapeutics 19 Dec 2013 124
12 Multiomics identifies metabolic subtypes based on fatty acid degradation allocating personalized treatment in hepatocellular carcinoma Binghua Li et al. · Hepatology Open access 4 Aug 2023 106
13 A subset of gastric cancers with EGFR amplification and overexpression respond to cetuximab therapy Lianhai Zhang, Jie Yang, Jie Cai et al. · Scientific Reports Open access 21 Oct 2013 87
14 Different syngeneic tumors show distinctive intrinsic tumor-immunity and mechanisms of actions (MOA) of anti-PD-1 treatment Ying Jin, Xiaoyu An, Binchen Mao et al. · Scientific Reports Open access 28 Feb 2022 74
15 Compensatory ion transport buffers daily protein rhythms to regulate osmotic balance and cellular physiology Alessandra Stangherlin et al. · Nature Communications Open access 15 Oct 2021 67
16 Controlled-release mitochondrial protonophore (CRMP) reverses dyslipidemia and hepatic steatosis in dysmetabolic nonhuman primates Leigh Goedeke, Liang Peng, Valle Montalvo-Romeral et al. · Science Translational Medicine Open access 2 Oct 2019 67
17 Drugging the catalytically inactive state of RET kinase in RET-rearranged tumors Dennis Plenker et al. · Science Translational Medicine Open access 14 Jun 2017 65
18 Carbon tetrachloride (CCl4) accelerated development of non-alcoholic fatty liver disease (NAFLD)/steatohepatitis (NASH) in MS-NASH mice fed western diet supplemented with fructose (WDF) Guodong Zhang, Xiaoli Wang, Tzu-Yang Chung et al. · BMC Gastroenterology Open access 15 Oct 2020 64
19 nmrML: A Community Supported Open Data Standard for the Description, Storage, and Exchange of NMR Data Daniel Schober et al. · Analytical Chemistry Open access 16 Oct 2017 63
20 The design, analysis and application of mouse clinical trials in oncology drug development Sheng Jie Guo, Xiaoqian Jiang, Binchen Mao et al. · BMC Cancer Open access 22 Jul 2019 62
21 Experimental animal modeling for immuno-oncology Qi‐Xiang Li, Gerold Feuer, Xuesong Ouyang et al. · Pharmacology & Therapeutics 4 Feb 2017 62
22 Raman Spectroscopy to Monitor Post-Translational Modifications and Degradation in Monoclonal Antibody Therapeutics Bethan S. McAvan, Leo A. Bowsher, Thomas Powell et al. · Analytical Chemistry Open access 2 Jul 2020 61
23 Serum proteomic analysis of diet-induced steatohepatitis and metabolic syndrome in the Ossabaw miniature swine Lauren Nicole Bell, Lydia S.H. Lee, Romil Saxena et al. · American Journal of Physiology-Gastrointestinal and Liver Physiology Open access 19 Feb 2010 59
24 Biogeography and Virulence of Staphylococcus aureus Juan Fan, Min Shu, Ge Zhang et al. · PLoS ONE Open access 10 Jul 2009 57
25 Enapotamab vedotin, an AXL-specific antibody-drug conjugate, shows preclinical antitumor activity in non-small cell lung cancer Louise A. Koopman, Mikkel G. Terp, Gijs G. Zom et al. · JCI Insight Open access 10 Oct 2019 56
26 Molecular Pathology of Patient Tumors, Patient-Derived Xenografts, and Cancer Cell Lines Sheng Jie Guo, Wubin Qian, Jie Cai et al. · Cancer Research 21 Jun 2016 56
27 NSCLC harboring EGFR exon‐20 insertions after the regulatory C ‐helix of kinase domain responds poorly to known EGFR inhibitors Mengmeng Yang, Xiaoxi Xu, Jie Cai et al. · International Journal of Cancer 18 Feb 2016 56
28 HnRNP A1/A2 and SF2/ASF Regulate Alternative Splicing of Interferon Regulatory Factor-3 and Affect Immunomodulatory Functions in Human Non-Small Cell Lung Cancer Cells Rong Guo, Yong Li, Jinying Ning et al. · PLoS ONE Open access 29 Apr 2013 56
29 Overcoming erlotinib resistance with tailored treatment regimen in patient‐derived xenografts from naïve Asian NSCLC patients Mengmeng Yang, Baoen Shan, Qiaoxia Li et al. · International Journal of Cancer 5 Sep 2012 53
30 Stimulation of alpha 7 nicotinic acetylcholine receptor (α7nAChR) inhibits atherosclerosis via immunomodulatory effects on myeloid cells Marcus A. Ulleryd, Filip Mjörnstedt, Dimitra Panagaki et al. · Atherosclerosis 15 Jun 2019 44
31 Fragment-Based Identification of Amides Derived from trans-2-(Pyridin-3-yl)cyclopropanecarboxylic Acid as Potent Inhibitors of Human Nicotinamide Phosphoribosyltransferase (NAMPT) Anthony M. Giannetti et al. · Journal of Medicinal Chemistry Open access 9 Jan 2014 42
32 Quinolones as HCV NS5B polymerase inhibitors Dange V. Kumar, Roopa Rai, Ken A. Brameld et al. · Bioorganic & Medicinal Chemistry Letters 22 Nov 2010 40
33 The Proteome of Normal Pancreatic Juice Courtney J. Doyle, Kyle W. Yancey, Henry Anthony Pitt et al. · Pancreas Open access Dec 2011 38
34 Distinct genomic landscape of Chinese pediatric acute myeloid leukemia impacts clinical risk classification Ting Liu, Jianan Rao, Wenting Hu et al. · Nature Communications Open access 28 Mar 2022 36
35 The FATZO mouse, a next generation model of type 2 diabetes, develops NAFLD and NASH when fed a Western diet supplemented with fructose Gao Sun, Charles V. Jackson, Karen M. Zimmerman et al. · BMC Gastroenterology Open access 18 Mar 2019 36
36 Mature B Cells Are Critical to T-cell-mediated Tumor Immunity Induced by an Agonist Anti-GITR Monoclonal Antibody Pengfei Zhou, Junzhuan Qiu, Lawrence L’Italien et al. · Journal of Immunotherapy 14 Sep 2010 35
37 Transcriptomic characterization and innovative molecular classification of clear cell renal cell carcinoma in the Chinese population Qiang Zhao, Xue Jia, Baoan Hong et al. · Cancer Cell International Open access 22 Sep 2020 34
38 Replication Study: The microRNA miR-34a inhibits prostate cancer stem cells and metastasis by directly repressing CD44 Xuefei Yan, Beibei Tang, Biao Chen et al. · eLife Open access 11 Mar 2019 34
39 Xylazine-induced reduction of tissue sensitivity to insulin leads to acute hyperglycemia in diabetic and normoglycemic monkeys Yong‐Fu Xiao, Bingdi Wang, Xiaoli Wang et al. · BMC Anesthesiology Open access 20 Oct 2013 33
40 Pharmacokinetic Optimization of Class-Selective Histone Deacetylase Inhibitors and Identification of Associated Candidate Predictive Biomarkers of Hepatocellular Carcinoma Tumor Response Jason Wong et al. · Journal of Medicinal Chemistry Open access 12 Oct 2012 31
41 Consensus subtypes of hepatocellular carcinoma associated with clinical outcomes and genomic phenotypes Sung Hwan Lee et al. · Hepatology Open access 29 Mar 2022 29
42 Occurrence of ochratoxin A in wine and beer samples from China Jianwei Wu, Yinfeng Tan, Yuqi Wang et al. · Food Additives and Contaminants Part B 11 Dec 2010 29
43 Humanized Mouse Models for Immuno‐oncology Drug Discovery Rajendra Kumari, Gerold Feuer, Ludovic Bourré · Current Protocols Open access Aug 2023 28
44 Molecular Characteristics of CTA056, a Novel Interleukin-2-Inducible T-Cell Kinase Inhibitor that Selectively Targets Malignant T Cells and Modulates Oncomirs Wenchang Guo, Ruiwu Liu, Yoko Ono et al. · Molecular Pharmacology Open access 17 Aug 2012 28
45 Statistical Assessment of Drug Synergy from In Vivo Combination Studies Using Mouse Tumor Models Binchen Mao, Sheng Jie Guo · Cancer Research Communications Open access 13 Oct 2023 27
46 Effects of a purified krill oil phospholipid rich in long-chain omega-3 fatty acids on cardiovascular disease risk factors in non-human primates with naturally occurring diabetes type-2 and dyslipidemia Petter‐Arnt Hals, Xiaoli Wang, Yong‐Fu Xiao · Lipids in Health and Disease Open access 17 Jan 2017 27
47 Efficient growth suppression in pancreatic cancer PDX model by fully human anti-mesothelin CAR-T cells Hua Jiang, Bo Song, Peng Wang et al. · Protein & Cell Open access 19 Sep 2017 26
48 Fragment-based design of 3-aminopyridine-derived amides as potent inhibitors of human nicotinamide phosphoribosyltransferase (NAMPT) Peter S. Dragovich et al. · Bioorganic & Medicinal Chemistry Letters Open access 21 Dec 2013 26
49 Left ventricular diastolic dysfunction in nonhuman primate model of dysmetabolism and diabetes Haihua Gu, Yongqiang Liu, Shuang Mei et al. · BMC Cardiovascular Disorders Open access 30 Oct 2015 26
50 A living biobank of matched pairs of patient-derived xenografts and organoids for cancer pharmacology Xiaoxi Xu et al. · PLoS ONE Open access 5 Jan 2023 24

Citations are OpenAlex's own counts, from its 2026-09-23 snapshot, so the ranking can differ from Google Scholar or Web of Science. A paper is listed for an institution when any of its authors gave it as an affiliation; retracted papers and papers whose citation count cannot be traced to citing works are left out, and a preprint and the article it became are shown once. Release dates are OpenAlex's: where a source gave only a month or a year, that is what is shown. How the lists are chosen.